Abbott Laboratories raised its full-year 2026 earnings guidance after reporting second-quarter results that beat analyst estimates, driven by robust performance in its diagnostics and medical device divisions.
U.S. Bancorp reported record quarterly revenue of $7.71 billion, a 10.1% year-over-year increase, driven by strong loan growth and a significant boost in fee income following its acquisition of investment bank BTIG.
Oracle's stock presents a stark contrast for investors, with a massive $638 billion revenue backlog pointing to future growth, while a recent credit downgrade to near-junk status and heavy cash burn raise significant financial concerns.
The European Commission has mandated that Alphabet's Google must provide competitors, including OpenAI, with access to key Android features and anonymized search data to comply with the Digital Markets Act (DMA).
The regulated prediction market introduced 13 new contracts, in partnership with AppliedXL, allowing traders to bet on events like FDA drug approvals for companies including Sanofi and Gilead.
Shares of Distribution Solutions Group (NASDAQ:DSGR) surged after the company agreed to be acquired and taken private by its majority shareholder, LKCM Headwater Investments, for $35.00 per share in cash.
The Australian cloud provider secured a five-year agreement with an unnamed global AI lab to deploy services in New Zealand, with revenue expected to begin in 2027.
Berenberg has downgraded German biotech firm Evotec SE and significantly cut its price target after the company lowered its full-year 2026 financial guidance due to delays in major partnership agreements.
HSBC has raised its rating on Indian equities to neutral from underweight, citing lower earnings risks, while maintaining its overweight stance on China as the bank warns of a more challenging phase for Asia's AI-driven market rally.
